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Cancer is a leading cause of death worldwide, and a mutation in the APC gene is an early 
event in the cancer progression leading to familiar adenomatous polyposis (FAP). Mutations 
in both alleles of APC will eventually lead to cancer, but the time of tumor development is 
dependent were on APC gene the mutation is located. 
 
Adenomatous polyposis coli (APC) is a tumour suppressor gene, with many critically 
functions in cellular mechanisms.  In the Wnt pathway it has been shown, that a mutations in 
APC leads to accumulation of B-catenin. During cell migration, during mitosis, APC 
coordinate microtubule and organize actin. The APC gene also modulates the long-patch base 
excision repair (BER) pathway, possibly changing the level of DNA damage after exposure to 
alkylating agents. Alternatively, the cells will enter apoptosis as a consequence of extensive 
DNA damage. There are many alkylating agents as well as food processed contaminants, that 
can either induce apoptosis or affect genotoxicity.  
 
In this thesis human embryonic cell were used. The cell line was heterozygous for the wild-
type APC gene (HEK-293K), and was used as a control cell line. The other cell line has a 
truncated APC gene with a mutation leading to a protein expressing only the first 750 amino 
acids of the APC gene (HEK-293 N750).  
 
In this study the effect of methyl methanesulphonate (MMS) on apoptosis in HEK-293K cells 
and HEK-293 N750 cells was investigated using flow cytometric analyses, as well 
investigating the effects of the mutagenic food processing contaminants furfuryl alcohol (FA) 
and glycidamide (GA) on genotoxicity, using the comet assay.  
 
 HEK-293K cells and HEK-293 N750 cells exposed to MMS did not increase the level of 
apoptosis in any of the cell lines. Western blotting was also performed on both cell lines, 
exposing with the alkylating agent MMS and see if cleaved- caspase-3 was detected, which is 
an indicator of apoptosis. No cleaved-caspase-3 was detected. 
 
For investigation on the genotoxic effects of FA and GA, the comet assay was used. FA did 
not give any increase in DNA damage at any of the doses (p= 0.992) or exposure times tested 
(p= 0.473).  There were no differences between the cell lines.  However, GA gave a dose-
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dependent increased in DNA damage (p< 0.001). When including formamido pyrimidine N-
glycosylase (FPF) enzyme treatment, even more DNA damage could be detected. This 
showed that FPG affects the treatment of glycideamide (p< 0.001).  
 
In conclusion, there were no indications that HEK-293K N750 cells were more sensitive 
towards MMS, and no apoptosis was observed. FA did not increase DNA-damage, but GA 
gave a dose-dependent increase in DNA-damage. The HEK-293 N750 cell line was not more 
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1. General introduction  
 
People with FAP have a mutation in the APC gene, and are therefore prone to develop colon 
cancer (Tominaga, Nita et al. 1998). The APC gene product has been found to play essential 
roles in many important cellular functions, such as the Wnt signaling pathway, microtubule 
and BER (Senda, Iizuka-Kogo et al. 2007). Impair or damage in these functions will lead to 
cancer, unless cellular defense mechanisms, like apoptosis, occur. Therefore it is interesting to 
investigate the association between HEK-293K cells and HEK-293 N750 cells. This can be 
done by using the alkylating agent model compound MMS.  
 
Food processing contaminants have been widely studied, like for example furan, 5-
hydroxymethylfurfural, and heterocyclic amines. Such compounds are of interest to study 
since many of them are possible carcinogens. Many of the food processed contaminants are 
themselves reactive, or form reactive metabolites, which gives genotoxic effects in the cells 
(Preussmann 1986). Since APC is essential for many cellular processes it is interesting to see 
if HEK-293 N750 cells are more prone to genotoxic effects. But so far only a limited number 
of dietary carcinogens have been identified and studied. This study investigates the genotoxic 
effects of FA and (GA).  
 
1.1 Food processing contaminants: acrylamide and FA 
 
Most of the food we eat is processed, prepared or preserved for storage in some way, which 
have advantages such as preventing growth of fungi, bacteria and other microorganisms. 
However, during such processes new substances may be formed, which were not present in 
the raw material. Many of these substances have been identified, and some shown to be 
hazardous and even carcinogenic to humans. They are often referred to as food processing 
contaminants (Preussmann 1986). Acrylamide (AA) and FA are two examples of food 
processing contaminants. 
 
AA is a typical compound that forms naturally in carbohydrate rich food upon heating 
through the Maillard reaction, at temperatures from around 120 °C and above. This reaction 
also contributes to colour and flavor of the food and is a complex series of non-enzymatic 
reactions between an amino acid, primarily asparagine, and a reducing sugar such as fructose 
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or glucose. Typically AA is formed during frying, baking, and roasting and is found in 
crackers, breads and breakfast cereal (Mucci and Wilson 2008).  
  
AA is neurotoxic in humans and a carcinogen in animals. Therefore it is classified as a 
probable human carcinogen by IARC (group 2A) (IARC 2000). Animal studies show that AA 
may be biotransformed to the epoxide GA by the CYP450 2E1 (CYP2E1) enzyme (Figure 1). 
This compound is thought to be more reactive than acrylamide itself (Kraus, Rokitta et al. 
2013).  
 
Animal studies show that AA, or its metabolite GA, cause genotoxic effects in animals and in 
cells in vitro (Knaap, Kramers et al. 1988, Ghanayem, McDaniel et al. 2005, Mei, Hu et al. 





Figure 1. Biotransformation of acrylamide to GA by P450 (Gamboa da Costa, Churchwell et 
al. 2003) 
 
Both AA and GA are electrophilically reactive substances, and are able to bind covalently to 
nucleophilic sites of proteins and DNA, where adducts are formed inducing DNA strand 
breaks (Doroshyenko, Fuhr et al. 2009). Detoxification happens during phase 2 metabolism 
by conjugating with glutathione (GSH) for urinary excretion (Fennell, Sumner et al. 2005) 
 
The food processing compound FA belongs to the substance group substituted furans which 
are furan derivatives consisting of the furan ring with different side-chain attachments. FA 
consists of a hydroxymethyl group and a furan ring.  
 
Furan is a compound consisting of a five-membered ring with four carbon atoms and one 
oxygen atom. Furan itself is genotoxic and carcinogenic in rodents, and is considered by 
IARC (1995) to be possibly carcinogenic to humans (group 2B).  
11 
 
FA is much less studied than furan, and most experiments performed with FA are inhalation 
experiments. Little is known about the potential hazard from oral exposure and concentrations 
in foods. However, FA is negative or only weakly positive in several conventional genotoxicy 
tests (Shinohara, Kim et al. 1986, Aeschbacher, Wolleb et al. 1989).  
 
FA is mainly oxidized to furfural. A 2-year gavage study on the carcinogenicity of furfural 
was published by the National Toxicology in 1990 (National toxicology program 1990). In 
rats, there was some evidence of carcinogenic activity, but only in males. There was clear 
evidence of carcinogenicity for male mice, based on increased incidences of hepatocellular 
adenomas and hepatocellular carcinomas. For female B6C3F1 mice there was some evidence 
of carcinogenic activity, based on increased incidences of hepatocellular adenomas (National 
toxicology program 1990). FA is then further oxidized to furoic acid and then conjugated with 
glycine to form furoylglyocine (Nomeir, Silveira et al. 1992) A recent study showed that 
small amounts of FA are bioactivated to a mutagenic compound, 2-sulfooxymethylfuran in 
Salmonella typhimurium strains expressing human sulfotransferase 1A1 and in FVB/N mice 
(Monien, Herrmann et al. 2011). This indicates that FA might need the presence of 
sulfotransferases to be activated. Standard genotoxicity tests have low levels of or completely 
lack sulfotransferases.  
 
1.2 Colon cancer 
1.2.1 Cancer incidence worldwide and in Norway 
 
Cancer ranks as one of the leading causes of death in the world. Colon cancer is the third most 
commonly diagnosed cancer, and the third leading cause of cancer death (Siegel, Naishadham 
et al. 2013)(Figure 2). This is the case for both men and women, with about 1.2 million new 
cases recorded annually (Ferlay, Shin et al. 2010). In Norway, there has been a stable increase 





Figure 2. Estimated age-standarised insidence and mortality rates. Colourectum cancer has 
the fourth highest incidence rate and mortality rate (Ferlay, Shin et al. 2010).   
 
1.2.2 Colon cancer and diet 
 
New data indicate that the risk of developing colon cancer is associated with environmental 
factors, such as diets and especially the Western diet (Cummings and Bingham 1998).  
Studies have shown that meat, in particular meat that has been well cooked, is a risk factor for 
colon cancer (Xu, Yu et al. 2013). There have also been studies that indicate that smoking, 
reduced activity, sedentary behavior and high consumption of fatty food, fatty sugar and 
alcohol is associated with increased risk of health disease (Gingras and Beliveau 2011). 
Populations moving from low to high risk areas adopt the higher risk level of the new area 
(Boyle and Levin 2008).   
 
1.2.3 Development of colon cancer 
 
Colon cancer develops in the colon or the rectum, and usually over a period of 10 to 15 years 
(Siegel, Naishadham et al. 2013). Tumour progression is driven by a sequence of randomly 
occurring mutations and epigenetic alterations of DNA that affect the genes controlling cell 
proliferation, survival and other traits associated with the malignant cell phenotype, and 
progress through a series of histological distinct stages (from early adenoma to metastasis) 
(Lao and Grady 2011). Oncogenes and tumour suppressor genes are found to be the type of 
genes that are frequently mutated, like for example the APC gene. When oncogenes become 
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mutated a certain function is turned on, whereas a mutation in a tumour suppressor gene leads 
to loss of function (Hunter 1997, Yeo 1999).  
 
The tumour normally begins as a noncancerous polyp (a growth of tissue that starts in the 
lining and grows into the center of the colon or rectum), and can develop to become 
cancerous. Adenomas are the kind of polyps that most likely become cancers (Siegel, 
Naishadham et al. 2013). The prognosis is highly dependent on the tumour stage (0 to IV) 




Figure 3. The overlaid stages (0-IV) of colon cancer, beginning with formation of an early 
adenoma (0), and finally ending in metastasis (IV) (The Daniel L.Edelstein Fund for the John 
Hopkins Colon Cancer Center [website]).  
 
1.2.4 Hereditary and spontaneous colon cancer 
 
The majority of colon cancers appear to be sporadic, but 3-5 % of the colon cancer cases in 
humans are caused by inherited syndromes (Narayan and Roy 2003). Examples of inherited 
colon cancer syndromes are the familial adenomatous polyposis (FAP) and hereditary 
nonpolyposis colorectal cancer (HNPCC), as well as defects in the mismatch repair system 
(Narayan and Roy 2003).  
 
The best understood heritable colon cancer syndrome is FAP, where the patients typically 
develop colon cancer at an average age of 42 years. Development of other tumours, including 
intra-abdominal desmoid tumours, osteomas, duodental adenomas and gastric adenomas may 




FAP is caused by germ- line mutations in tumour suppressor APC (Tominaga, Nita et al. 
1998).  Since one allele already has damage due to mutation, the remaining allele will be 
vulnerable towards damages such as environmental impacts. Both APC alleles must be 
mutated for disease to develop.(Kinzler and Vogelstein 1996).  
 
This gives rise to the susceptibility to develop hundreds to thousands of adenomatous polyps 
in the colon (Figure 4). Such polyps themselves non-malignant, but are prone to develop into 
carcinomas. This is due to the large number of adenomas that developed, and together with 
their early onset, there is a 100% risk of colon cancer formation from one of the adenomas. 
There has been shown, by use of genetic analysis, that the position of the inherited mutation 
within the APC gene affect the number of adenomatous polyps and average age of cancer 
onset (Arends 2013). 
 
 
Figure 4. The overlaid stages (0-IV) of colon cancer, beginning with formation of an early 
adenoma (0), and finally ending in metastasis (IV) (The Family History of Bowel Cancer 
Clinic [website]).  
 
Colon cancer is most frequently a result of mutations in the tumour suppressor APC gene, 
where CIN is associated with this mutation (Arends 2013). Mutations in the APC gene are 
inactivating mutations found in about 80% of all colon cancers, both sporadic and inherited, 
and in both adenomas and carcinomas. This occurs early in the sequence of colon cancer 









1.3.1 APC gene and its product 
 
The APC gene is a classical tumour suppressor gene located on chromosome 5q21 locus that 
codes for the 310 kDa- homodimeric multifunctional APC protein. The protein comprises an 
8538-bp open reading frame and encodes the 2843 amino acid (Brocardo, Lei et al. 2008, 
Qian, Sarnaik et al. 2008). The structure of the protein can be seen in figure 5.  
APC is normally expressed in nonproliferating colorectal epithelium, and is localized both in 
the cytoplasm and nucleus (Narayan and Roy 2003). The protein comprises a number of 
functional domains, motifs and other signatures, and can therefore perform many cellular 
functions through its different binding partners, besides tumour suppression. Some of these 
functions are control cell proliferation in the epithelium of the colon, cell differentiation, cell 
adhesion, chromosomal segregation, migration, apoptosis and neuronal functions (Senda, 





Figure 5. Structure of the human APC protein. The protein contains multiple domains 








1.3.2 APC and the Wnt pathway 
 
One of the most studied functions of APC is its role in the Wnt signaling pathway. Loss of 
both alleles will lead to cancer, since the Wnt pathway is always active. This signaling 
pathway directs cellular proliferation and differentiation, as well as cellular morphology, 
motility and the fate of embryonic cells (Narayan and Roy 2003, Senda, Iizuka-Kogo et al. 
2007, Polakis 2012).  
 
In the bottom of the colon crypts APC is hardly expressed, but there are high levels of B-
catenin. Upwards in the crypt the expression of APC increases, and here APC act as a 
regulator of the Wnt signaling pathway by negatively regulating the levels of B-catenin in the 
cytosol (Senda, Iizuka-Kogo et al. 2007). 
 
APC opposes Wnt signaling by acting in a complex with axin and glycogen synthase kinase 
(GSK3β) to target the transcription factor β-catenin (McCartney and Nathke 2008). The 
binding of β-catenin is done through APC’s 15 aa repeats, whereas the seven motifs of 20 aa 
also bind β-catenin and facilitates down regulation of β-catenin (Luchtenborg, Weijenberg et 
al. 2004). Thereby β-catenin becomes phosphorylated, targeted for ubiquitination and 
degraded by the proteosome, and controlled cell growth is maintained (Neufeld 2009).  
 
Mutations in the APC gene can cause premature termination of translation of the APC 
protein, and generate a short APC protein, which lack domains that are important for its 
ability to associate with β-catenin and axin. This reduces the degradation of B- catenin, and 
B-catenin escapes its degradation through the Wnt signaling pathway and becomes stabilized 
in the cytoplasm. This has a profound effect on the cell, as it allows accumulation of B-
catenin, followed by migration to the nucleus where it actively transcribes cell cycle related 
genes causing cellular proliferation (Giles, van Es et al. 2003, Narayan and Roy 2003). 
Cascades of events are thereby activated, leading to tumour genesis. The mechanisms 






Alternations in B-catenin regulation are very common in human tumours. The accumulation 
of β-catenin is probably the most and important consequence of APC inactivation, which can 





Figure 6. A simplified illustration of the Wnt signaling pathway. To the left: When Wnt is 
bound to the receptor on the cell surface, GSK- 3β will be inactivated. As a consequence, the 
complex with APC will not form and B-catenin will not be degraded. B-catenin will instead 
accumulate in the cytoplasm, migrate to the nucleus and bind to a transcription factor where 
genes that are important for cell growth are turned on. To the right: B-catenin is degraded 
when bound to GSK-3β/Axin/APC complex (Senda, Iizuka-Kogo et al. 2007).  
 
1.3.3 APC and microtubuli 
Mitosis is the part of the cell cycle where the nucleus is divided and is immediately followed 
by cytokinesis. Mitosis can be broken down to five stages: prophase, promethaphase, 
metaphase, anaphase and telophase. Many events of mitosis depend on the mitotic spindle, 
which plays an essential part in the first four stages. This structure consists of fibers made of 
microtubules and associated proteins. The elongation of the microtubule happens by 
incorporating more subunits to the structure.  
The assembly of spindle microtubule starts at the centrosome, which replicate and move 
apart. During this process the spindle microtubule begins to form. In the promethaphase the 
microtubule and its plus ends are attached to the kinetochores (Green and Kaplan 2003). 
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During metaphase the spindle structure becomes completed and moving toward opposite ends 
of the cell, during anaphase, can separate the chromatids. Motor proteins associated with the 
kinetochore microtubules perform movement of chromosomes.  
There are many proteins associated with the correct segregation of chromosomes during 
mitosis, but this is still under study (Cheeseman, Drubin et al. 2002). The APC protein can 
bind to microtubule and also interact with a number of microtubule associates proteins. It has 
been shown that APC is localized near the distal ends of microtubule (Mimori-Kiyosue, 
Shiina et al. 2000, McCartney and Nathke 2008). The multifunctional APC protein thereby 
plays an important role by coordinating microtubule and organizing actin during cell 
migration (Buda and Pignatelli 2011).  
APC contains multiple domains that facilitate binding with other proteins, for example tip-
binding proteins (for example KAP 3, EB1, mDIA or Asef) at the end of microtubule 
(Watanabe, Wang et al. 2004, Wen, Eng et al. 2004). Binding of APC to those proteins assists 
the movement of APC along microtubule, where APC accumulate at the plus ends of 
microtubule. This drives the formation of membrane protrusions, which direct cell 
movements (Buda and Pignatelli 2011). Binding to some of the plus-end binding proteins are 
needed for accurate chromosome segregation, and contribute to the movement of APC along 
the microtubule (Senda, Iizuka-Kogo et al. 2007). The ability APC has to localize the plus 
ends of microtubules contributes to stabilization of microtubule (Tighe, Johnson et al. 2004). 
During interface APC is also localized to centrosomes and to kinetochores in a microtubule 
dependent manner during mitosis (Tighe, Johnson et al. 2004).  
When thinking of the many roles APC plays during mitosis it is not surprising that loss of 
APC leads to changes in cell migration, cell orientation, cell polarity and cell division. Mutant 
APC has been shown to predispose cells to increased mitotic abnormalities (Arends 2013). 
High rates of chromosomal instability (CIN) have been reported as an underlying cause of 
colon cancer (Green and Kaplan 2003). There has been shown that in Xenopus egg extracts 
depleted of APC protein changes in microtubule density occured, resulting in the formation of 
weaker spindle. Whereas in human cells with APC mutations there has been reported aberrant 
spindle structures and weakened kinetochore (Green and Kaplan 2003, Dikovskaya, Newton 
et al. 2004). There has been shown that truncated APC proteins can result in chromosome 
instability, which can drive the accumulation of mutations, including loss of the second APC 
allele in FAP patients (Tighe, Johnson et al. 2004). In cells expressing N-terminal fragments 
19 
 
of APC similar effects have been observed (McCartney and Nathke 2008). In cells 
heterozygous for Apc 
min  
mutation in Apc show aberrant chromosome segregation, which 
leads to CIN (Husoy, Cruciani et al. 2003). 
 
1.3.4 APC and DNA repair 
 
The structural integrity of DNA is continuously subjected to a number endogenous processes 
and exogenous substances, as well as to bi- products from the cell´s own metabolism (reactive 
oxygen species), which lead to DNA damage. Such influences can affect the maintenance of 
the genomic integrity, and potentially lead to mutations and be a reason for carcinogenesis if 
not repaired. Cells possess several defense mechanisms to repair different kind of DNA 
damage and to eliminate damaged cells. Several different repair pathways exist, which are 
activated upon DNA damage. These pathways stall the cell cycle progression and thereby 
provide more time for repair of the damage (Bartek, Bartkova et al. 2007).  
 
The major repair pathways in mammals are excision base repair (nucleotide excision repair 
and base excision repair) and recombination repair (homolog recombination and non-homolog 
recombination).   
 
The APC gene can modulate the long-patch base excision repair (BER) pathway when there is 
too much damage. APC levels increase, following blocking of DNA- polymerase β (Pol- β) 
and flap endonuclease 1 (Fen-1), which thereby prevent the pathway (Balusu, Jaiswal et al. 
2007, Jaiswal and Narayan 2008). However, these effects on the cells ability to repair are not 
fully understood.  
 
If the damage is too significant for the cell, DNA repair will not be possible. Defects in these 
mechanisms make the cells more sensitive toward DNA damaging agents, which may have 








1.5 Apoptosis and necrosis  
 
Based on the cell´s proliferative status, capacity of repair enzymes and ability to induce 
proteins that promote cell death, a cell can undergo different types of cell death if there is too 





Figure 7. Different responses a cell has towards stress (Okada and Mak 2004). 
 
Apoptosis is programmed cell death that requires adenosine triphosphate (ATP), and is a well-
defined process with characteristic morphology (Kerr, Wyllie et al. 1972). 
 
In multicellular organism, apoptosis is essential for normal cell development, differentiation, 
homeostasis and embryogenesis. Apoptosis is especially important when it comes to 
regenerating of tissues, for example in the crypt-villus intestinal structure where there is 
apoptotic elimination of cells at the tip of the villus (de Jesus Perez, Yuan et al. 2012). 
 
Apoptosis serves to eliminate old cells, cells having undergone DNA damage, cells being 
infected and inappropriately proliferating cells (Leist and Jaattela 2001, de Jesus Perez, Yuan 
et al. 2012).   
 
The mechanisms behind apoptosis are mediated by caspases, a family with cysteine proteases 
(Kouzmenko, Takeyama et al. 2008). Two major pathways trigger caspase activation and 
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apoptosis; the death receptor pathway and the mitochondrial pathway, where initiating events 
and downstream events distinguish them (Tang, Mura et al. 2008). 
 
Casapses are expressed as inactive pro-caspases precursors, which undergoes proteolytic 
activation. Caspases are grouped into initiators (caspase-2, -8, -9 and -10) and effectors 
(caspase-3, -6 and -7). The first group is activated in response to particular cell death and 
developmental signals, and cleaves the precursors forms of the effector caspases. The effector 
caspases become activated and execute apoptosis by cleaving other proteins necessary for cell 
survival (Tang, Mura et al. 2008). Active caspase- 3 is a protein that gets activated during the 
early phase of apoptosis, and starts when caspase- 3 gets cleaved into a shorter protein 
(Shrivastav, De Haro et al. 2008). 
 
Caspases digest designated cellular proteins, which leads to breakdown of the cell down to 
apoptotic bodies, without disrupting the cellular membrane (Figure 8) (Jaattela 2004). The 
apoptotic cells are recognized by changes in the plasma membrane and phagocytized by cells 
of the immune system. This prevents leakage of cellular content of the surroundings and is 
considered less inflammatory (Fadeel and Orrenius 2005).  
 
If apoptosis fails accumulation of cells will occur, resulting in abnormal cell proliferation, 
where cancer is the worst outcome (Bratton and Cohen 2001).  
 
Necrotic cell death is often a passive process, and is frequently a result of ATP depletion. It is 
characterized by irreversible increased cell volume, organelle swelling, loss of plasma 
membrane integrity and intracellular content (Figure 8) (Asare, Landvik et al. 2008, Tang, 
Mura et al. 2008). This releases cellular components, affecting the surrounding cells causing 







Figure 8. An overview of apoptosis and necrosis. Necrosis is characterized by swelling and 
rupture of the cell membrane, and apoptosis is characterized by several apoptotic bodies 
(Robertson and Orrenius 2000).  
 
 
1.6 Alkylating agents  
 
Alkylating agents are a class of anticancer drugs that bind to DNA and prevent proper DNA 
replication. These compounds also occur as mutagens and carcinogens in the environment 
(Peto, Gray et al. 1984).  
 
The simplest alkylating agents, primarily methylating and ethylating agents, are not normally 
considered an environmental contaminants, but are used as model compounds for reactive 
forms of many carcinogens (Beranek 1990). MMS  is such a model compound, and has been 
used for a long time as an alkylating agent that causes DNA damage, and gives double strand 
breaks (DSB) (Lundin, North et al. 2005, Benchabane and Ahmed 2009). MMS modifies 
guanine (to 7-methylguanine) and adenine (to 3-methyladenine), causing mispairing and 
replication blocks, respectively, as well as it can give rise to DSB. When there are DNA 
repair pathways that are compromised, cells exposed to MMS show an increased sensitivity 
(Lundin, North et al. 2005).  
 
Another anticancer drug is the alkaloid camptothecin (CTP), which intercalates between DNA 
bases and amino acid residue. It is a highly selective topoisomerase I (TOP1) inhibitor, where 
inhibition of this enzyme impairs transcription and DNA replication, resulting in DSB in the 




1.7 Flow cytometry 
 
Flow cytometric measurements are widely used for analyzing different cell types in a solution 
of heterozygous population, where multiple parameter analysis of a single cell can be 
determined.   
 
Flow cytometric measurements can also discriminate cells in the different parts of the cell 
cycle: the G1-, S-, G2- and M-phase. Distribution of cells in the major phases of the cell cycle is 
based on differences in DNA content. Since G2- and M-phase have identical DNA content flow 
cytometric measurements cannot discriminate between the two. Discrimination is based on 
DNA content (for example by Hoechst 33258 fluorescent), cell size (forward scatter) and cell 
granularity or internal complexity (side scatter). When using flow cytometry to analyze 
apoptosis, apoptotic cell bodies will emit fluorescent signals that are lower than those of G1 
because of chromosome condensation and nuclear fragmentation, and are therefore called 
sub-G1 (Wiger, Finstad et al. 1997). 
 
Cells are prepared from a sample, stained with different fluorochromes (that attach to proteins 
or DNA), and passed through a laser and optic detection system. A sheat fluid ensures that 
only one cell at the time passes the detection system, with a great capacity (>300 cells/second) 
to acquire and analyze. However, samples should be analyzed at rates below 1000 cells per 
second in order to yield a good signal of discrimination between singles or doublets. Cells of 
interest in a population are gated and doublets are discriminated. Diverse software can be 
used to fit a DNA histogram where percentages of cells occupying different phases of the cell 
cycle are calculated(Otsuki, Li et al. 2003). 
 
 
1.8 Western blotting 
 
Western blotting is a widely applied analytical technique used for separation and 
identification of expression levels of proteins, and was first described by Towbin and 
colleagues (Towbin, Staehelin et al. 1992). In order to separate proteins in a cell lysate, 
samples prepared from biological material are diluted and cooked in a buffer containing 
sodiumdodecylsulfat (SDS), mercaptoetanol, glycerol and bromphenol blue. Cooking of the 
sample at 95°C breaks the secondary and tertiary structure of the proteins, and 
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mercaptoethanol ensures that the proteins do not form these structures again thereafter.  SDS 
gives the proteins a negative charge, bromphenol blue gives colour to the protein lysate and 
last but not least, but not least, glycerol ensures the right viscosity. Equal amounts of proteins 
are separated by electrophoresis, using polyacrylamide gel. Electrophoresis is performed in an 
electrophoresis tank filled with buffer that can carry current. Proteins with negative charge 
will migrate away from the anode. With electrophoretically transfer the proteins are moved 
from the gel and onto a nitrocellulose support membrane, where they become immobilized.  
In order to immobilize the proteins on the membrane, the membrane is placed between filter 
paper, sponge pads, and on top of a nitrocellulose membrane as well. This sandwich-like 
packing is placed in a tank with buffer solution, where the transfer occurs. In order to prevent 
nonspecific binding the membrane is blocked (Gershoni and Palade 1983, Towbin, Staehelin 
et al. 1992) 
 
The specificity of Western blotting is achieved by using antibodies (monoclonal or 
polyclonal) that recognizes and binds to an epitope unique to the protein of interest. 
Furthermore, a secondary antibody, conjugated with horse raddish peroxidase (HRP), is added 
and binds to the primary antibody- antigen complex. To detect the antigen-antibody complex 
the membrane gets incubated with chemiluminnescent. The HRP on the secondary antibody 
leads to an enzyme reaction with light as product, which can be detected using a film or 
digital imaging. To identify proteins a standard protein ladder is used. The principle behind 
Western analysis can be seen in the figure below (Figure 9) (Kurien and Scofield 2006). 
 
 




1.9 Comet assay 
 
The single cell gel electrophoresis assay (SCGA), also called comet assay, due to the comet-
like shape of nuclei formed after electrophoresis of damaged DNA (Figure 10), is a simple, 
effective and inexpensive method for measuring DNA damage. The comet assay can be 
performed under neutral or alkaline conditions, where the first one in generally more sensitive 
(Collins, Dobson et al. 1997). Basically, when using the alkali comet method, DSB and alkali-
labile sites (ALS) can be detected. There are various specific enzymes (enzymes that cut 
DNA at specific locations) that can be used before the electrophoresis step to detect multiple 
DNA damage. The use of formamido pyrimidine N-glycosylase (FPG) is wieldy used, and is 
recommended for the detection of oxidative DNA basa damage. It removes oxidized purines 
and formamidopyrimidines, and also attacks ring-opened N7 guanine adducts produced by 
alkylating agents (Li, Laval et al. 1997) . 
 
 
Single cell suspension is prepared from cell culture (in vitro) or from the tissue (in vivo). The 
cells are embedded in agarose-gel, on a film, and lysed. After lysis of the cells overnight, the 
electrophoresis step is performed. The double strand break DNA will migrate (towards the 
anode) to form a comet-like tail. The size of the comet tail will be proportional to the amount 
of DNA damage (Gutzkow, Langleite et al. 2013) Azqueta and Collins 2013). 
 
This method is very sensitive, allowing a few thousand of lesions in each cell to be detected; 
it is relatively simple and cost-efficient, and a very low number of cells may be used.  
 
     
 
Figure 10. Damage cells (to the left) look like a “comet” under the microscope, compared to 
undamaged cells (to the right) (own picture). 
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1.10 Aims of study 
 
By using cells with a normal functioning APC protein (HEK-293K) and a truncated form 
(HEK-293 N750) of the protein, one aim of this study was to explore the effects of MMS on 
apoptosis.  
 
1. Is there any likelihood that cells with mutated APC are more sensitive and undergo 
apoptosis when using MMS? 
 
A second aim was to clarify effects of the mutagenic food compounds FA and GA. 
 
2. Will exposure to FA or GA cause increased DNA damage? 
3. Is more DNA damage observed for GA, when using FPG? 


















2. Materials and methods 
 
Information about products, instruments, software and producers can be found in appendix 1-
3.   
 
There are many methods available for detection of cell death. In this study apoptosis was 
investigated, and flow cytometry was found to be a useful method, as it can give useful 
information of apoptotic cells by discriminating between cell size and DNA content. 
Apoptotic cells have smaller size and less DNA content than the cells in the G1 phase, and 
can be visualized. For staining the cells, there are different types available, the Hoechst 33258 
(Invitrogen) was chosen. Another reason for choosing the method was that it is efficient, 
allowing quantification of a high amount of cells.   
 
Activation of different caspases by cleavage is a molecular marker for apoptosis. Caspase-3, a 
key player in the process of apoptosis, and cleaved-caspase-3 was investigated with Western 
blotting. This can give information about the activity of a protein.  
 
The comet assay was chosen as the method for detection of DNA-damage because of its 
sensitivity and because only a small number of cells is needed. Another advantage is that 
when using FPG enzyme, more information of DNA damage can be provided.  
 
2.1 Cell work 
2.1.1 The cell line  
 
In this study human embryonic kidney cells, HEK-293, from Great Britain was used. This is a 
cell line transfected with the APC gene with three different mutations, which are N750, 
N1309 and N1807. The mutants are expressed as Myc-proteins and they code for the first 
750, 1309 and 1807 amino acid of the APC gene (Tighe, Johnson et al. 2004). These 
mutations cause different length of the APC protein, which gives the opportunity to study the 





In this study the cell line with the N750 mutant APC (HEK-293 N750) was used, as well as 
the cell line heterozygous for wild- type APC (HEK-293K), which was used as control. Both 
of the cell lines were used in all experiments, and they were given the same treatments.  
 
The HEK-293 N750 cells were generated to express the Myc-tagged N-APC mutants under 
tetracycline control (Tighe, Johnson et al. 2004). To induce the truncated form of the APC 
protein, in the HEK-203 N750 cells, the medium used prior to an experiment contained 
tetracycline hydrochloride (0.01µg/ml). The same treatment was given to the HEK-293K 
cells, this was done in in order to give the two cell lines the same treatment. 
2.1.2 Sterile technique 
 
The study involved working with living cells and accuracy concerning sterile technique, 
which had to be performed correctly to avoid contamination and to maintain a clean and 
sterile working environment. The cell work took place in an approved ventilated cabinet 
(DanLaf) in order to maintain sterile condition as well as to prevent exposure to dangerous 
substances. Personal safety equipment was always used, and protective goggles if needed.  
The material data safety sheet was always read prior to an experiment.  
2.1.3 Cell culture  
 
The cell lines were cultivated in plastic culture flasks (75 cm
2
 flask) (Starstedt) with 15 ml of 
the cell culture medium, Dulbecco’s Modified Eagle Medium (DMEM) (VVW).  
 
The flask was kept in a humidified incubator (Thermo Steril- Cycle CO2 incubator) at 37°C 
with 5% CO2 humidified air. The cap of the flask was always slightly opened when being in 
the incubator in order to ensure equilibrium of the CO2- gas in the incubator and the cell 
medium.  
 
A 500 ml flask of DMEM contained 4.5 g/l D-Glucose, L-Glutamine and pyruvate. DMEM 
was supplemented with 10% Fetal Bovine Serum (FCS) (Biochrom), L-Glutamine (2mM) 
(Sigma Aldrich) and 1% penicillin/streptomycin (P+S) (Lonza). Medium with these 
supplements will in the rest of this document be called medium. The HEK-293 N750 cell line 
was grown in medium that also contained hygromycin B (Hyg. B.)(0.2 mg/ml) (Invitrogen 




All medium was used at physiological temperature. Medium/Hyg.B. was made in advance 
because Hyg. B lowers the pH, and the pH needs to be normalized before medium/Hyg. B is 
being used. Since DMEM and Hyg. B. are light sensitive, these solutions were kept in the 
dark until being used.  
 
The cells were passaged approximately every third day depending on when they were needed 
in an experiment. The process of splitting the cells involved removing the old cell culture 
medium with suction (Integra vacusafe) and washing the cells with Dulbecco Phosphate- 




 was used. 
 
To detach the cells from the bottom of the cell culture flask, trypsin/EDTA (170000 U/l) 
(trypsin) (Lonza) was added. To a big flask (75 cm
2
) 1 ml trypsin (Lonza) was added, and to a 
small flask (25 cm
2
 flask) 0.333 ml was added. The flask was put to incubation for 2 minutes, 
at 37°C. Detachments of the cells were controlled under the light microscope. Thereafter, 
medium was added to stop the trypsination, and also to obtain a cell suspension. The resulting 
cell suspension was placed in a 15 ml tube. After resuspending the cells, some of them were 
aliquoted to a new cell culture flask and put for incubation until the next split was necessary.  
 
To obtain the right cell density for the experiments, the number of cells in the cells suspension 
was counted. In the beginning of our experiments a Bürkner counting chamber (Labor 
Optik®) was used in order to determine the concentrations of the cell suspension. The rails of 
the Bürkner counting chamber (Labor Optik®) were moistened with distilled water and a 
cover glass was placed on top of the counting chamber. Trypan blue stain (Lonza) was used to 
discriminate between dead and living cells. An intact cell membrane of a living cell will 
exclude the colour, and in cells where the cell membrane is damaged and in dead cells trypan 
blue to cross the membrane and stain those cells. A desired dilution of the cell suspension 
with medium and trypan blue stain (Lonza) was made, and 10 μl of the dilution were pipetted 
under the cover glass. The cells were counted under a light microscope (Nixon) using a 10X 
objective. The averages for both chambers were calculated, and this number was used as the 








In a 2x dilution the amount of cells per ml is calculated like this; the amount of cells per 
square x 1000 x 2. In a 10x dilution the amount of cells per ml is calculated like this; the 
amount of cells per square x 10000 x 10. 
 
An automatic cell counter (BioRad) along with cell counting chamber slides (BioRad) was 
later on used to count the cells. The cells were diluted 1:1 with trypan blue stain (Lonza), and 
10 µl of the dilution was added to the counting chamber slide (BioRad).  
 
Depending on the experimental method, the proper amount of cells was taken out from the 
cell suspension and placed in a flask or a dish along with medium.  (Table 1). The different 
amounts of cells used for flow cytometry depended on when they were further used. If they 
were used the next day a higher amount was needed, opposed to when they were used two 
days later.  
 




Amount of cells Container   Volume of medium 
(ml) 







Flow cytometry 15-40 x 10
6








 flasks 5 
 
 
The dishes/flasks were placed in the CO2 incubator until used. Before exposing the cells to a 
chemical, the medium was changed approximately 10 minutes before starting the treatment. 
In all experiments, except for the comet assay, preformed with GA, medium with supplements 
was used. In the experiment with GA, medium with no supplements was used in order to 




When exposing the cells to a chemical, the chemical was added to the medium surrounding 
the cells. Since the amounts of the different chemicals were low (µl) no equivalent amount of 
dimethyl sulphoxide was added to the control cells. The exposure concentration of the 
different chemicals can be seen in tables 2 and 5.  
 
2.2 Flow cytometry 
 
2.2.1 Preparing the cells for Flow cytometry 
 
The cells were prepped for an experiment in the same way as described under the section “cell 
culture”. The dishes were grown to near 80% confluence before treatment with a chemical 
(Table 2). Both cell lines got the same treatment. The experiment was carried out four 
independent times.  
 
Table 2. Treatments given to the cells, along with concentrations.  
Treatment  Control CTP and MMS  CTP  MMS 
Concentration 
of treatment 
0 mM 10 µM and 600 
µM 
10 µM 600 µM 
 
 
The exposure duration always consists of two independent times. The duration of treatment 
with CPT lasted for 1 hour and 6 hours. The duration of the treatment with MMS lasted for 
1hous and 15 minutes as well as 5 hours and 15 minutes. The treatment with the combination 
of the chemicals lasted for 1 hour and 6 hours (Figure 11). No time line for the control 













A. CPT exposure 
 
 
B. MMS exposure 
 
C. Exposure of CPT and MMS 
      
Figure 11. An overview of the treatment times and lengths. A. CPT time line B. MMS time 
line. C.  Timeline for the combination of CPT and MMS 
 
After ended exposure, old medium was removed and the cells were washed 2 times with PBS 
before trypsination (Lonza). Medium with 20% FCS (PAA The Cell Culture Company) was 
used to stop trypsination. The cell suspension was transferred to a 15 ml tube (Sarstedt) and 
kept on ice, until 3 minutes centrifugation at 700 rpm. The supernatant was removed, and 1 
ml medium with 20 % FCS (PAA The Cell Culture Company) was used to resuspend the 
pellet. From the cell suspension a 500 µl sample was taken out and prepared for flow 
cytometry. This involved fixation of the cells, where a sample got added 2% 
paraformaldehyde (PFA) (Sigma Aldrich). The cell suspension was put in BD Falcon 5ml PS 
tubes (BD Biosiences) and stored in the refrigerator until use.  
 
About 15 minutes before flow cytometric measurements the DNA of the cells were stained, 
with a 1:1 mixture of Hoechst 33258 (1 µg/ml) (Sigma Aldrich)  and Trition X-100 (10% ) 
(Thermo Scientific).  
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The samples were kept in the dark while not being analyzed by BD LSR II flow cytometer 
(BD Biosciences). Before recording data for a sample, the sample was gently vortexed.  
 
2.2.2 Flow cytometric measurements 
 
The number of events to acquire was set to 10 000. The threshold rate was regulated if 
needed. The blue laser (480nm) was used, and for measuring Hoechst the detector Alexa 
Fluor 405 was used. The G1 peak was set to 100, and the apoptotic index was determined as 
the percentage of signals between the G1 peak and the channel positioned at 20% of the G1 




2.3 Western blotting 
 
Western blotting was performed in order to check if the HEK-293 N750 cells expressed the 
truncated form of the APC protein, and to check for apoptosis. This was done using Anti-APC 
(Ab-1) monoclonal antibody (Calbiochem) for detection of the truncated APC protein in the 
HEK-293 N750 cells. The polyclonal antibody Caspase-3 (Cell Signaling) was used for 
detection of apoptosis. The cells were prepped for an experiment in the same way as 
described under “cell culture”, and three independent replicates of the experiments were 
performed.  
 
The different treatments and treatment concentrations can be seen in table 2. The duration of 
the treatments are the same as in figure 11, but with an additional time scenario: 25 hours and 
49 hours for CPT, 24 hours 15 minutes for MMS,  and 25 hours and 40 hours for the 
combination of them (Figure 12). There is no time line shown for the control treatment as this 








A. CPT exposure  
 
 






C. CPT and MMS exposure  
          
       
 
Figure 12. An overview of the treatment times and lengths.  A. CPT time line B. MMS time 
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2.3.1 Harvesting cells 
 
After ended exposure times the adherent cells were harvested on ice. Medium was removed 
with suction (Integra vacusafe) and PBS was gently added 2 times in the corner of the dish to 
rinse. PBS was removed by suction and cell paper was used to remove redundant PBS from 
the corners. The dishes were placed in a -20°C freezer for about 5 minutes before being stored 
in a -70°C freezer until further use. The dishes were placed on ice and lysates were made by 
adding, 200 µl of lysis buffer to each dish. A cell scraper was gently used and the lysate was 
transferred to an eppendorf tube and sonicated 5 pulses, each lasting one second with 
amplitude of 30, before the lysates boiled for 5 minutes at 95 °C. Centrifugation for 10 
minutes at 12 000 rpm followed. The supernatant was moved to a new eppendorf tube, and 
the pellet was discarded.  
 
 
2.3.2 Protein measurements 
 
Lysat was diluted 1:10 in distilled water. The standard curve (four parametric curve) was 
made in distilled water and bovine serum albumin. Concentrations being used for the standard 
curve were: 4, 2, 1, 0.5, 0.3, 0.125 mg/ml.  
 
BioRad DC Protein Assay (containing solution A, B and S) (BioRad) was used to measure 
protein amount. To a microtiterplate four replicates with 5 µl of each sample and three 
replicates with 5 µl of the standard curve, as well as three replicates distilled water was added.  
Further, 25 µl of Reagent A containing 2% of reagent S and 200 µl reagent B was added to 
the whole plate. The plate was placed in the dark for 15 minutes in order to obtain colour 
development, and absorption was measured in a plate reader at 750nm and analyzed with the 
software Gen 5. Lysis buffer was added to adjust the wanted protein concentration. The 








2.3.3 Electrophoresis and blotting 
 
Proteins were separated in polyacrylamide gels (Mini-Protean TGX Precast gels) (BioRad). 
Depending on the protein of interest, 12.5% or Any % kDa gels were used, and each well had 
a total amount of protein of 12.5, 18.75 or 14.0 µg/µl (Table 3).  
 
Table 3. The percentages of the gels being used and the total amounts of protein applied.  
% of the gel Total amount of protein Protein of interest 
Any % kDa  12.5 µg/µl 
 18.75 µg/µl 
 APC 
12.5 %  12.5 µg/µl 
 14.0 µg/µl 
  Caspase- 3 
 
Before applying the samples, the wells were rinsed with electrophoresis buffer, in order to get 
rid of possible rests from the buffer, from the manufacturing process. The samples were 
vortexed and applied to the wells. In order to allow direct visualization of the sample mobility 
during electrophoresis and for precise sizing of proteins, 10 µl Precision Plus Protein 
Prestained Standard Dual Xtra (BioRad) was added to a well. Electrophoresis was run at 
100V until the samples had gathered to a straight line, and was sat up to 200V. While running 
electrophoresis the electrophoresis chamber was placed in a plastic box, encircled with ice.  
 
Proteins where transferred onto a nitrocellulose membrane (Whatman®) by electro blotting. 
Blotting was carried out in transfer buffer for 30 minutes at 100V and then for 1 hour at 70V. 
The step was done with an ice block in the blotting chamber to keep the temperature low, and 
in order to maintain cold circulation of the transfer buffer, a magnet stirrer was used. 
Ponceau-staining was used to control the protein loading. Prior to probing the membrane with 
antibody, the membrane was blocked in washing buffer solution (TBS buffer) with 3% dry 
milk for at least 30 minutes, at room temperature, and with shaking. This was done in order to 
avoid unspecific binding. Subsequently, the membrane was washed 3 timed for 10 minutes 
with TBS buffer. 
 
Different antibodies and dilutions were used in the different experiments to detect the 
different proteins of interest, along with a corresponding HRP-conjugated secondary antibody 
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(Table 4). Incubation with primary antibody, in TBS with 1% dry milk, was always 
preformed over night at 4 °C, and with shaking. Incubation with HRP-conjugated secondary 
antibody, in TBS with 1% dry milk, was always preformed at room temperature, and with 
shaking 
 






Ab-1 1:500 Anti- mouse 
HRP 
1:5000 
Caspase-3 1:1000 Anti- rabbit 
HRP 
1:5000 





The next day the membrane was washed 3 times for 10 minutes with TBS, before incubation 
with HRP-conjugated secondary antibody (Dako). This was performed at room temperature 
on a shaker for 1-2 hours. 
 
The proteins were visualized by using Super-Signal® West Dura Extended Duration substrate 
(BioRad), according to the manufactures protocol. Equal amounts SuperSignal®West Dura 
Luminol/Enhancer Solution and SuperSignal®West Dura Stable Peroxide buffer were added 
to the membrane and incubated in the dark for 3-5 minutes. Image Lab Analysis Software 
(BioRad) was used for visual quantification of the protein bands.  
 
Finally, the membrane was re-probed with the primary antibody B-actin as a loading control. 
This was done in each Western experiment. This secondary antibody was also incubated in 








2.4  Comet assay 
 
For the comet assay the cell lines were exposed with two different substances, FA and GA. 
For both chemicals dose-response experiments were performed with three independent 
replicates, and with the FA time curve two independent replicates were performed. Treatment 
with the FPG enzyme was included in the experiments with GA.  
 
2.4.1 Preparing the cells for comet assay 
 
The cells were prepped for an experiment as described under the section “cell culture”. The 
next day the flasks were controlled under a microscope (Nixon TMS Type 104) to see if the 
cells had attached to the bottom of the flask. Different concentrations were used for the 
different chemicals, in the different experiments, and with different incubation times (Table 
5).  
 
Table 5. An overview of the concentrations of the chemicals in the different experiments. 
Type of experiment and incubation time is listed as well. 
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When exposing the cells with FA, the stock solution was made fresh in medium, immediately 
before exposure. During incubation the cap was properly closed in order to prevent the 
chemical to evaporate. When exposing the cells with GA, the stock solution was made fresh 
in PBS. The cells were incubated in the CO2 incubator according to the times given in table 5. 
The further procedure was the same for both chemicals.  
 
The exposure treatment for both compounds was terminated by removing the old medium, 
washing the cells 2 times with PBS, and treatment with trypsin (Lonza). Medium was added 
and the cell suspension was transferred to a tube and centrifuged for 3 minutes at 700 rpm. 
The cell pellet was gently resuspended to 10
6
 cells/ml in medium, and stored on ice. The 
following steps were done in dim light or in the dark if nothing else is specified.  
 
Low melting soft agarose (0.75%) (Cambrex) was dissolved, in PBS containing 10 mM 
EDTA (pH 7.5), heated in a microwave and stored on a 37°C heating block. Agarose was 
mixed with cells in a 1:10 dilution.  
 
GelBond® film (Cambrex) were cut to size 8.5cm x 12.5cm, with a cut in the bottom right 
corner of the film and with holes in each of the corers (Figure 13). The film was attached to 
plastic frames to simplify handling between the different treatment steps following later on. 
For each exposure sample 4 parallels with 4 µl agarose/cell mixture were placed onto the 
hydrophilic side of a GelBond® film (Cambrex) while sited on a cold plate. Immediately after 
embedding the gels and thereby immobilizing the cells, the films were put for lysis, using 





Figure 13. A typical setup on a GelBond® film (Cambrex). The picture shows the different 
treatments of each cell type, and where each sample is replicated as 4 parallel gels 
(horizontal) on the film. 
 
The next day the films were rinsed with distilled water, and placed in electrophoresis buffer at 
4°C for 5 minutes and then in new electrophoresis buffer for 35 minutes in order to unwind 
DNA. The film was immersed onto a platform in an electrophoresis tank, using the same 
solution used for DNA unwinding. Electrophoresis lasted for 20 minutes in the dose-response 
experiment with FA and 25 minutes in all other experiments, at 8°C.  V/cm over the platform 
was always between 0.8-1, mA was approximately 700 and the voltage was 25.  Since DNA 
is negatively charged it will move towards the anode, giving the appearance of a comet tale.  
 
The next steps in the procedure took place at room temperature. The film was neutralized in 
neutralization buffer for 2 times for 5 minutes and then fixed in ethanol for at least 90 
minutes, before it was put to dry in the dark. 
 
For further analysis the film was re-hydrated and stained with SybrGold (1x) which was 
diluted in TE-buffer, for 20 minutes. Excess stain was washed off with distilled water. The 





Analysis of DNA tail migration was performed using a Leica DMLB fluorescence microscope 
(using 20X lens) equipped with CCD-camera, and single cells were semi-automated scored by 
the use of Comet IV capture system (version; Perspective Instruments, Liverpool, UK). For 
each gel 30 cells were randomly counted when having 4 parallels.  
 
In the experiments done with GA, the enzyme FPG was used as well, for detection of 
oxidative DNA damage. Samples were both untreated and treated with FPG, which recognizes 
specific lesions and converts them to strand breaks. In order to determine the optimal 
concentration of FPG for the cells, an enzyme titration was done in the HEK-293K cell line.  
 
2.4.2 Enzyme titration 
 
Seven samples containing 500 µl of cell suspension (1 million cells/ml) was used. Different 
treatments were given to the samples (Table 6). Samples 1-3 were controls, while the rest of 
the samples were treated with the photosensitive ethyl 7-okso-7h-tieno[2,3-A]-quinolisin-8-
carboksylate (RO)(Ro 12-9786)(RO)(3µM) (a gift from Dr. Elmar Gocke). This was done in 
order to induce oxidative DNA-damage by use of a light source.  
 
Table 6. Different treatments with RO, 1100 LUX exposures and lengths of exposure 
given to the different samples. A positive (+) sign indicates that the sample got the 
corresponding treatment, and a negative (-) sign indicate that the treatment was not 
given to the sample. The three first samples, 1-3, were controls.  




LUX exposure  
1 - - - 
2 + - - 
3 - + 10 
4 + + 2 
5 + + 4 
6 + + 6 




When working with RO, double sets of nitrile gloves were used as a safety measure, since the 
chemical is mutagenic. Since RO is light sensitive the following steps were performed by 
keeping the samples in the dark. When exposing the cells treated with RO the samples, were 
held under a light source (1500, cold light) 
 
Embedding the cells on the GelBond film was done as described above. The next day the 
films were quickly rinsed in distilled water before being put in Collins buffer (50ml/film) at 
4°C. After 10 minutes the old Collins buffer was removed and new was added for 50 minutes. 
While the films were treated in Collins buffer the enzyme buffer was prepared. Collins buffer 
(at room temperature) was added BSA (0.2 mg/ml) and preheated at 37 °C for approximately 
an hour.  
 
For the pre-enzyme treatment, the enzyme was thawed and diluted 1:100 in Collins 
buffer/BSA. Incubation with enzyme lasted for 1 hour with the following final concentrations 
for FPG; 0, 0.01, 0.1 and 1 µg/µl. Thereafter the same steps are followed as described above 
(the steps from when the films were placed in unwinding buffer).  
 
When scoring the films and analyzing the data, the optimal enzyme concentration was 
evaluated to be 1 µg/ml (Figure 14), which was used in the experiment with GA. When using 
FPG the steps with Collins buffer described under “Enzyme titration” are the same. Also, 









Figure 14. Titration curve of FPG created in a dose dependent manner. Saturation (DNA 
damage observed) was detected after FPG 0.1µg/ml added. The highest concentration of FPG 
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2.5 Statistical analysis 
 
Using statistics, data can be analyzed and one can draw general conclusions based on a 
limited set of data. One can discriminate between real observations or observations by chance. 
Data were analyzed using SigmaPlot (SigmaPlot software; Jandel Scientific, Erkrath, 
Germany). The graphs were also made with this program. 
 
In this study, three identical, independent experiments were carried out, except for the 
experiment with FA with different time points. Because of time limitations this experiment 
was only performed two times. Each experiment is considered as a biological replicate. In 
each sample in the comet assay method, four technical replicates were used. This was mainly 
done in case of unforeseen challenges with the method.  
 
For each sample 120 single cells were scored, with 30 single cells per replicate. In one of the 
experiments with FA there was no HEK-293 N750 cells present in the 24h sample. Therefore 
no statistical analyses have been done on that time.    
 
The median % tail-DNA intensity value was extracted from the raw data for each sample in 
each experiment. The experiment has more than two groups and two or three factors, and 
thus, the Two-Way-ANOVA or Three-Way-ANOVA would be an appropriate tests. 
However, since the sample size is small (n=3), it may be difficult to detect assumption 
violations such as, non-normality and inequality of variances even when they are present. 
Some statistical packages include an option for a non-parametric test for the Two-Way-
ANOVA. This is not the case for SigmaPlot, and instead a rank transformation has been used 
on the data before using the standard Two-Way-ANOVA test. Holm-Sidak method was used 
to identify which groups differed from one another. Significant differences (p< 0.05) 
compared to control is indicated by an asterisk (*).  
 
Conocer and Iman already described the use of ranked data in parametric methods in 1981, 
and they named this method “The rank transformation approach”. Note that the Kruskal-
Wallis test is a rank transformation approach of the One-Way-ANOVA test (Conover WJ 




Vertical point plot was chosen as the best representation of the data, since it shows the 
variance in the different experiments. The median of each technical replicate was plotted for 
each flask. In the text, the results are presented as the calculated means of the medians (of the 


































3.1 Flow cytometry 
 
Cellular measurements by flow cytometric analysis made it possible to assess the individual 
cells within a population and look at their DNA content. HEK-293K cells and HEK-293 N750 
cells were stained with Hoechst 33258 (1 ug/ml), and the amount of apoptotic cells (Sub- G1) 
in the cell sample, were analyzed.  
To investigate the cell cycle and state of apoptosis, in the cell lines, flow cytometric analysis 
was used, and the relative amount of cells in the cell lines were approximately: 63-65 % (G1), 
22-25 % (S) and 6-10 % (G2) compared to only 1-4 % (Sub-G1) of the total population 
(Figure 15).  
Then the cell lines got different treatments to examine if the treatment with MMS and /or CPT 
had an effect on the cell cycle or induced apoptosis, by examining the relative amount of cells 
in the different parts of the cell cycle (Figure 15).  
There were no effects observed on apoptosis for any of the treatments, and also not any 
difference between the cell lines (Figure 15). Sine there were no effects on apoptosis, only 
histograms of control treatment as well as the treatment with CTP and MMS (discriminating 
between the times) is shown. The whole representative presentations from one out of four 





















A.1: 1.67  %  ± 0.66 
A.2: 1.67  %  ± 0.66 
A.3: 2.58  %  ± 1.80 
Living cells:  
A.1:  98.00 %  ±  0.74 
A.2:  98.00 %  ±  0.74 
A.3: 97.85 %  ±  0.41 
G1:  
A.1: 62.50 %  ±  1.20 
A.2: 62.50 %  ±  1.20 
A.3: 67.68 %  ± 1.90 
S: 
A.1: 22.30 %  ±  0.76 
A.2: 22.30 %  ±  0.76 
A.3: 21.65 %  ±  2.40 
G2:  
A.1: 15.22  %  ±  1.90 
A.2: 15.22  %  ±  1.90 





Treatment with CPT (10 µM) 




Treatment with CPT (10 µM) 


















B.1: 3.45 % ±1.35 
B.2: 2.45 % ± 0.84 
B.3: 2.8 % ±1.08 
Living cells:  
B.1: 96 %  ± 1.76 
B.2: 97.35 % ± 0.79 
B.3: 96.6 % ± 1.24 
G1:  
B.1: 61.85 % ± 2.66 
B.2: 63.25 % ± 7.36 
B.3: 64.58 % ± 4.00 
S: 
B.1: 24.1 % ± 0.84 
B.2: 24.75 % ± 4.69 
B.3: 26.03 % ± 2.42 
G2:  
B.1: 14.05 % ± 2.67 
B.2: 12 % ± 3.09 




Treatment with CPT (10 µM) 
and MMS (600µM)  
1 hour MMS  
 
HEK-293 N750, 
Treatment with CPT (10 µM) 







Figure 15.  Flow cytometric analysis of HEK-293K (A1-3)) cells and HEK-293 N750 cells 
(B1-3)). The histograms that are shown represent treatment with CTP (10µM) and MMS (600 
µM), from one out of 4 independent experiments. The y-axis shows the number of cells (cell 
count) and the x-axis shows the DNA content (measured by using Hoechst 33258 (1 µg/ml)). 
The histograms are divided into apoptosis and living cells. The values in the box under the 
histograms are quantifications of the flow cytometry experiments. All values shown are the 
average from the four experiments along with standard deviation.  
 
 
3.2 Western blotting 
 
Western blotting was performed on the HEK-293 N750 cell line to confirm the expression of 
the truncated form of the APC gene. The HEK-293K cells, which lack the truncated APC, 
was used as control. Medium with tetracylcine hydrochloride (0.01µg/ml) was used on the 
HEK-293 N750 cells to induce truncated APC. Western blotting analysis with antibody (Ab-
1), specific to the amino terminus of APC, was used. This antibody will detect both full length 
and truncated APC. B-aktin was used as a loading control.  
 
The Western blot depicts 3 independent experiments for each cell line. Lane 1-3 represents 
HEK-293K cells, and lane 4-5 represents HEK-293 N750 cells (Figure 16). A protein with 80 
kDa (indicated by an arrow), was the truncated protein expressed by the HEK-293 N750 cells, 
and was only detected in all of the HEK-293 N750 samples (Figure 16). Furthermore, both 
cell lines also express an unknown protein in the Western blots, which is likely to be a cross-
reaction of an unknown protein with the APC antibody. Since the aim of this experiment was 
not to quantitate the amounts of APC in HEK-293 N750 cell line, but only to verify the 











                    
 
 
Figure 16. Three experiments with HEK-293K cells (lanes 1-3) and HEK-293 N750 cells 
(lanes 4-6), was performed to detect expression of the truncated HEK-293 N750 form of the 
APC gene. The primary antibody being used was Ab-1, and B-actin antibody was used for a 
loading control. 
 
Western blotting was also used to investigate apoptosis in the HEK-293K and HEK-293 N750 
cell. The cells were exposed to CTP (10µM), MMS (600 µM) and a combination (Figure 17 
and 18).   
 
Caspases are normally activated by cleavage of the protein when apoptosis is executed, and 
therefore cleaved- caspase- 3 can be used as a marker for apoptosis. The presence of caspase-3 
and cleaved-caspase-3 was investigated using the antibody cleaved- caspase 3. As a loading 
control B-aktin was used (Figure 17 and 18).  
 
A protein with molecular weight at 35 kDa was detected, which is likely to be the caspase-3 
protein. No cleaved-caspase-3 was detected after treatments in any of the cells lines.  Western 
analysis revealed that caspase- 3 is up-regulated in in both cell lines, and in almost all the 
treatments given (Figure 17 and 18), even though only weak bands could be detected in lane 






Figure 17 show higher level of  caspase-3 protein in HEK-293K cells  in the long time 
exposure compared to the shorter exposure time, and also higher levels were found in the 
HEK-293K cells compared to HEK-293 N750. However, due to un-even protein loading, both 
within lanes with the same cell line and between the cell lines, no firm conclusion can be 









Figure 17. The figure shows representative Western blots of HEK-293K cells (lanes 1-7) and 
HEK-293 N750 cells (lanes 8-14), using caspase-3 (n=3). Lanes 1-7 are: control (0 mM)/ 
CPT (10 µM) and MMS (600 µM)/ CPT (10 µM)/ MMS (600 µM)/ CPT (10 µM) and MMS 
(600 µM)/ CPT (10 µM)/ MMS (600 µM), with the following exposure times: 1 hour/ 1 hour/ 
1 hour/ 1 hour 15 minutes/ 6 hours/ 6 hours/ 5 hours 15 minutes. The same order was in lanes 





















Figure 18. The figure shows representative Western blots of HEK-293 cells (lanes 1-7) and 
HEK-293 N750 cells (lanes 8-14), using caspase-3 (n=3). Lanes 1-7 are: control (0 mM)/ 
CPT (10 µM) and MMS (600 µM)/ CPT (10 µM)/ MMS (600 µM)/ CPT (10 µM) and MMS 
(600 µM)/ CPT (10 µM)/ MMS (600 µM), with the following exposure times: 48 hours 15 
minutes / 49 hours / 49 hours / 48 hours 15 minutes/ 49 hours / 49 hours / 48 hours 15 

















3.3 Comet assay – testing of genotoxicity  
 
3.3.1 FA induced genotoxicity in HEK-293K cells and HEK-293 N750 cells  
 
The comet assay was used to measure the potential genotoxic effects of FA on the cells, and 
the experiment was replicated three times. The cells were treated with millimolare 
concentrations of FA (0, 0.5, 3 and 10 mM) for 3 hours. FA did not induce any detectable 
genotoxic effects at any tested dose. There was no statistically significant difference between 




Figure 19. Dose-response curve of FA in the comet assay. The HEK-293K cells and HEK-
293 N750 cells were exposed for 3 hours. The x-axis shows the different cell culture (in a 
flasks) and the y-axis shows % Median Tail Intensity. The vertical lines separate the 
treatments, with 3 experiments for the same treatment within each box. From left to right the 
treatments are: 0 mM control (flask 1-3), 0.5 mM (flask 4-6), 3 mM (flask 7-9) and 10 mM 
(flask 10-12). Each symbol represents the % Median Tail Intensity of one technical replicate.  
 
The highest concentration of FA (10 µM) from the dose-response experiment was used to 
perform two independent experiment with different exposure times (0, 1, 5, 7 and 24 hours) 
(Figure 20), to investigate if changes in exposure time would increase DNA damage. Time 
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did not increase the effect of FA on DNA damage measured by the comet assay (p= 0.473). 
However, there seems to be a slight difference in DNA damage between the cell lines, where 
HEK-293K shows a trend to have more DNA damage than the HEK-293 N750 cells, but this 
is not statistically significant (p= 0.063).  
 
  
Figure 20. Time-curve with FA in the comet assay. The HEK-293K cells and HEK-293 N750 
cells were exposed to 10 mM FA 5 different times. The x-axis shows the different cell culture 
(in a flasks) and the y-axis shows % Median Tail Intensity. The vertical lines separate the 
time with 2 experiments for the same treatment within each box. From left to right the 
treatments are: 0 hour (flask 1-2), 1hour (flask 3-4), 5 hours (flask 5-6), 7 hours (flask 7-8) 
and 24 hours (flask 9-10). Each symbol represents the % Median Tail Intensity of one 
technical replicate.  
 
3.3.2 DNA damage induced in HEK-293K cells and HEK-293 N750 cells by GA 
 
The comet assay was used to detect DNA damage after exposure to GA. To assess DNA base 
modifications we used the comet assay with lesion-specific endonuclease, FPG (1 µg/ml).  
 
In a pilot experiment (not shown) different dose of GA was tested (0.5, 2 and 5mM) for 2 
hours. Treatment with FPG at the lowest dose induced 100 % DNA-damage compared to the 
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control. This was the case for both cell lines. Since this was a pilot used for further 
experiments, no statistics was performed.  
 
Based on the pilot, lower doses of GA were used (0.05, 0.1, 0.5 mM) in three independent 
experiments. After two hours exposure time DNA damage could be detected in a dose 
dependent manner, with and without the use of FPG (Figure 21).  
 
In the treatment, where FPG was not included, the treatment had a statistically significant 
impact on the induced DNA damage (p< 0.001).  For both cell lines increased DNA damage 
was observed for each dose (HEK-293K lowest to highest dose: 14.14±3.34, 14.91±5.71, 
39.14±3.56. HEK-293 N750: 17.00±3.53, 22.02±3.54, 40.19±1.05) compared to the control 
(HEK-293K: 3.88±0.86 HEK-293 N750: 8.54±1.26). However, there was no statistically 
significance between the cell lines (p=0.09).   
 
Further, when including FPG (1 µg/ml) there was a statistically significant increase in 
induced DNA- damage (p< 0.001). For both cell lines increased DNA damage was observed 
for each dose (HEK-293K, lowest to highest dose: 66.08±12.80, 68.37±6.35, 97.26±0.58. 
HEK-293 N750: 59.78±6.23, 69.44±3.84, 96.18±1.08) compared to the control (HEK-293K: 
12.73±3.66. HEK-293 N750: 15.24±1.06). However, there was no statistically significance 
























         A. Without FPG 
 
       
      B. With FPG 
 
 
Figure 21. DNA damage induced by millimolar concentrations of GA, measured in the comet 
assay with FPG enzyme (1 µg/ml) and without. HEK-293K cells and N750 cells were 
exposed to GA for 2 hours. The x-axis shows the different cell culture (in a flasks), and the y-
axis shows % Median Tail Intensity. Each symbol represents the % Median Tail Intensity of 
one technical replicate. From left to right the treatments are: control (flask 1-3), 0.05 mM (4-





In 2004, Tighe and colleagues published an article where they observed that cells transfected 
with APC mutations could initiate chromosome instability. In that study HEK-293 cells were 
used, expressing either full length APC or mutants; N750, N1309 and N1087 (Tighe, Johnson 
et al. 2004). In the described experiments cells transfected with mutant APC, HEK-293 N750 
cells, compared to control cells, HEK-293K cells was studied. Western blotting was 
performed to confirm if the truncated protein was still present in the HEK-293 N750 cells. 
This was important prior to the experiment so that it would possible to draw conclusions of 
potential differences between the cell lines based on truncated APC protein compared to 
normal APC protein.  
 
In the master degree by Heidi Nyland, it was found that MMS induced DNA damage in the 
comet assay, which was more slowly repaired in the HEK-293 N750 cell line compared to the 
HEK-293K cells (Nyland 2008). This can be due to reduced DNA repair in cells with DNA 
damage, or higher apoptosis activity in the HEK-293K cells due to the DNA damage. It was 
therefore interesting to measure apoptosis in the HEK-293 N750 cell line after exposure to 
MMS compared to HEK-293K line, as this was not performed in the master degree of Heidi 
Nyland. In the described experiments DNA damage was also studies in the cell lines.  
 
The cells were exposed to the known mutagenic compound MMS for the apoptosis studies, 
and to the two food processing contaminants, FA and GA for the comet assay. No effect was 
observed on apoptosis in cells exposed to MMS, and there were no difference with or without 
mutated APC. FA did not increase DNA damage in any of the cell lines, while GA increased 
the DNA damage with equal potency in both HEK-293K cells and HEK-293 N750 cells 
 
4.1 Apoptosis and the influence of truncated APC 
 
APC may play an important role in carcinogenesis, by determine whether cells with DNA 
damage survive or undergo apoptosis.  APC participate in the regulation of Wnt signaling, 
and the Wnt signaling pathway has been shown to both positively and negatively regulate 
apoptosis (Benchabane and Ahmed 2009). Therefore, cells with truncated APC may have 
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impaired apoptosis, and as a consequence be more sensitive to DNA damage, by alkylating 
agents.  
 
The results from the flow cytometric measurements on apoptosis, measurements in HEK-
293K cells and HEK-293 N750, after treatment with CTP alone or in co-exposure with MMS, 
showed no increase in the level of apoptosis. By using CTP alone and together with MMS it 
was anticipated a higher level of DNA damage in the HEK-293 N750 cells, since it was 
reported in an article by Kaina and colleagues (2012), that CTP inhibits TOP1. One of the 
important functions of this protein is in DNA repair (Tomicic and Kaina 2013).  
 
The results rare not in accordance with the results shown in a master degree by Heidi Nyland 
(2008), where it was found that MMS induced p53 in the HEK-293 N750 cell line, shown by 
Western blotting, while the induction in the HEK-293K cells was less evident (Nyland 2008). 
Since p53 is activated in the early onset of apoptosis, this indicates that some of the cells 
might go into apoptosis due to DNA damage rather than repair the DNA damages, and that 
this might be more pronounced in cells with mutations in APC, but this was not observed.  
 
Activation of caspases is responsible for the characteristic morphology of apoptotic cells 
(Earnshaw, Martins et al. 1999, Roos and Kaina 2006), and cleavage of caspase 3, resulting in 
cleaved-caspase-3, was used as an indication of apoptosis. Detection of cleaved- caspase-3 
was analyzed by Western blotting of proteins from HEK-293 N750 and HEK-293K cells, but 
only the parent caspase-3 was detected, after exposure to MMS.  
 
This was surprising, since mutagenic anticancer drugs, such as MMS, induce DSB in DNA 
and thereby leading to apoptosis. The detection of DSB is very rapidly. Low levels of DNA 
damage trigger DNA repair, while high levels of DNA damage induces apoptosis (Roos and 
Kaina 2013). The concentration of a drug will influence response of the cells, and often high 
concentrations induces apoptosis (Sundquist, Moravec et al. 2006). There is a possibility that 
the used concentrations were too low for detection of apoptosis, but any increase in 
concentration would not have been realistic. However, the negative results are in accordance 
with the negative results on apoptosis using flow cytometry, described above. 
 
Thige and colleagues found that cells with expression of an N-APC mutant could induce CIN 
in a dominant manner. They found that expression of N750 reduced the accumulation of cells 
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in mitosis following spindle destruction, and they suggested that N750 mutant could 
compromise the spindle checkpoint. Mitotic spindles are shorter in the cells expressing the N-
APC fragments. Expression of N750 alone did not appear to induce CIN (Tighe, Johnson et 
al. 2004). It is therefore interesting to speculate if the proper terms for expressing apoptosis 
are present in our experiments. 
 
As an alternative to undergoing apoptosis, necrosis of the cells could have occurred. 
Apoptosis inducing signals can induce necrosis rather than necrosis, if there is inappropriately 
high concentrations of a drug concentration (Sundquist, Moravec et al. 2006). Necrosis can 
also be due to inhibition of mitochondrial respiration or inactivation of caspases (Nicotera, 
Leist et al. 1999). This type of cell death, will not be detected in the apoptosis measurements, 
by flow cytometery, and also not by Western blotting if caspases are inactivated.  
 
In cultured cells, induced to undergo apoptosis, indications of apoptotic events occur much 
sooner than (5-10 hours) than cells within tissues (11-14 hours) (Sundquist, Moravec et al. 
2006). Therefore it is possible that MMS induces apoptosis, but the timing for measuring 
apoptosis was wrong, however, this is just speculations.  
 
4.2 DNA repair and the influence of the truncated APC 
 
Exogenous and endogenous mutagenic agents attack the genomes of all living cells, resulting 
in the generation of damaged DNA bases. BER is the main pathway for the repair of 
endogenous abasic DNA damage, and blocking of BER by APC leads to apoptosis (Jaiswal 
and Narayan 2008). The role of APC in DNA repair was initially discovered by determine its 
interaction with proliferation cell nuclear antigen (PCNA), which is known to participate in 
BER. Changes in APC can therefor interfere with DNA repair, and cells, like the HEK-293 
N750 cell line, may therefore be more sensitive to alkylating agents, like MMS, or genotoxic 
compounds from food. DNA alkylating agents, like MMS, have been shown to induce APC, 
and induced level of APC can block BER and increase the level of DNA damage. The 
exposure of HEK-293 N750 cells and HEK-293K cells, to MMS, in the comet assay was 
already studied in the master degree of Heidi Nyland (2008), and showed that MMS induced 
DNA damage in both cell lines with approximately the same potency (Nyland 2008). DNA 
alkylating agents induce a variety of DNA lesions, which may have individual contribution to 
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cytotoxicity and various genotoxic end points, including chromosomal aberrations that are not 
yet fully understood   
 
However, two other food processing contaminants, FA and GA, were studied in the comet 
assay, to detect DNA damage after the HEK-293 N750 cells and HEK-293K cells, but only 
GA increased the DNA damage. The N750 cells were not more sensitive to DNA damage by 
GA than the HEK-293K cells, indicating that APC do not change the repair of the DNA 
damages, from GA.  This is not in accordance with publications indicating that BER may be 
involved in the repair of DNA adducts formed by GA (Johansson, Lundell et al. 2005, 
Pingarilho, Oliveira et al. 2012) since polymorphism in genes important to BER increase the 
susceptibility to GA induced DNA damage (Pingarilho, Oliveira et al. 2012). 
 
 
4.3 The genotoxic effects of compounds from heat processed food 
 
Our data on FA, with three different doses, did not show a genotoxic affect on the HEK-293 
N750 cells or HEK-293K cells. In another study by Gomez-Arroyo and colleagues (1985), 
they also did not find any genotoxic effect, when investigating sister chromatid exchange, on 
human lymphocytes (Gomez-Arroyo and Souza 1985). This is in unity with the results in a 
study by Mortelmans colleagues (1986) where they tested mutagenicity of FA in four 
different strains of Salmonella typhimurium without any increase in DNA mutations. Another 
sturdy with Salmonella typhimurium showed that small amounts of FA are bioactivated to a 
mutagenic compound, 2-sulfooxymethylfuran in strains expressing human sulfotransferase 
1A1 and in FVB/N mice (Monien, Herrmann et al. 2011). This indicates that FA might need 
the presence of sulfotransferases to be activated.  
 
 
FA is much less studied than furan, and most experiments performed with FA are inhalation 
experiments. Little is known about the potential hazard from oral exposure and concentrations 
in foods.  A 2-year inhalation study performed by the National Toxicology program (NTP) 
showed that FA induced renal tubule neoplasms in mice and nasal neoplasms in rats. NTP 
concluded that there was “some evidence of carcinogenic activity” (National toxicology 
program 1999). However, FA is negative or only weakly positive in several conventional 




Also in a study by Stich et al. (1981) they observed that FA had clastogenic activity in 
Chinese hamster ovary cells (CHO) (Stich, Stich et al. 1981). If FA mainly has clastogenic 
activity, it cannot be expected to increase DNA damage in genotoxicity test that only detect 
DNA mutations, like the Ames tests. 
 
In the pilot study with GA there was a significant effect already from the second exposure 
dose, and the response in the comet assay increased when using FPG. The treatments given to 
the cells showed a dose-dependent effect relative to the control. Our results are consistent 
with a study done by Hansen and colleagues (2010) where they found that GA induced DNA 
damage in mouse and human peripheral blood lymphocytes, at millimolare concentrations. 
The found a dose-dependent association between the different treatments, and they also found 
a dramatic effect in the amount of DNA damage when using FPG (Hansen, Olsen et al. 2010).  
In another study by Besaratinia et al. (2004) they also reported dose-dependent effects of GA, 
and they found that GA was more mutagenic than acrylamide (Besaratinia and Pfeifer 2004). 
 
However, it is difficult to comparing the results from this study to other studies. This is 
because nobody has studied the HEK-293K and HEK-293 N750 cells in the comet assay. 
There are methods for detecting genotoxicity, but comparisons are hard to draw since the 



















In this study the effect of MMS on apoptosis in cells with normal APC (HEK-293K) and 
truncated APC (HEK-293 N750) was investigated.  
 
1. There were no indications that HEK-293K N750 cells were more sensitive towards 
MMS, and no apoptosis was observed.  
 
The effects of the mutagenic food compounds FA and GA was investigated. 
 
2. FA did not give a genotoxic effect, since no increased DNA-damage was observed. 
GA gave a dose-dependent increase in DNA-damage. 
3. The use of FPG increased the DNA-damage observed for each dose different from the 
control dose. 
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Appendix 1: Products and producers 
 
Product       Producer 
Albumin bovine (BSA)     Sigma Aldrich, USA  
Aprotinin Sigma Aldrich, USA 
Anti-APC (Ab-1) Calbiochem, Germany 
β- actin Sigma Aldrich, USA 
B- Mercaptoetanol Sigma Aldrich, USA 
CTP Sigma Aldrich, USA 
Cellulose filterpaper Sigma Aldrich, USA 
DC Protein assay Bio-Rad, USA 
DMEM VWR, USA 
DMSO Merck, Germany  
Dry milk Fluka, Switzerland 
EDTA Sigma Aldrich, USA 
FCS PAR The Cell Culture Company 
Glycerol Sigma Aldrich, USA 
Glycin Sigma Aldrich, USA 
HCI Merck, Germany 
Hoechst 33258 Invitrogen, USA  
Hyg. B. Invitrogen, USA 
L-Glutamine Sigma Aldrich, USA 
Leupeptin Amersham Biosiences, Sweden 
Metanol Lab-Scan, Polen 
MMS Sigma Aldrich, USA 
Na2EDTA Sigma Aldrich, USA 
NaOH Merck, Germany 
Natrium orthovandat Sigma Aldrich, USA 
Natrium pyrophosfat Sigma Aldrich, USA  
Paraformaldehyd Sigma Aldrich, USA 
PBS Dulbecco 
Pepstatin A Calbiochem, USA 
PMSF(phenylmethylsulfonyl fluoride?) Sigma Aldrich, USA 
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P+S Lonza, Belgium 
Polyclonal Goat Anti-Rabbit Immunoglobulins/HRP Dako, Denmark 
Polyclonal Rabbit Anti-Mouse Immunoglobulins/HRP Dako, Denmark 
SDS Fluka, Switzerland 
Super Signal West Dura Extended Duration Substrate Thermo Scientific, USA 
Sybr®Gold Invitrogen, USA 
Tris-base Sigma Aldrich, USA 
Triton X-100 Sigma Aldrich, USA 
Trizma hydrochlorine Sigma Aldrich, USA 
Trypan blue stain Bio Whittaker, Lonza 
Trypsin EDTA Lonza, Belgium 

























Appendix 2: Instruments and software 
 
Instruments       Producer 
Bio Rad TC10™ Automatic cell counter   Bio-Rad, USA 
TC10™ System Counting Slides, bud chambers  Bio-Rad, USA 
Bürker counting chamber     Labor Optic 
Seri Cycle CO2 incubator     Thermo Electron 
25cm2/75cm2  Culture Flasks    Sarstedt 
Vacusafe       Integra, USA 
Sonicator       Sonic&Materials, USA 
Chemi-Doc       Bio-Rad, USA   
 
    
Software       Producer 
BDB FACSDiva™ Software     BD, USA 
Gen5        BioTek, USA 
ImageLab       Bio-Rad, USA 
 


















Appendix 3: Buffers and solutions 
 
Solutions and chemicals that were not sterile from before or autoclaved, were sterile filtered 
before getting applied to the cells.  
 
Washing buffer 
10 mM Tris- HCl buffer 12 g 
0.15mM NaCl   80 g 
0.1% v.v. Tween 20  10 ml  
Fill ut to 100 ml distilled water, adjust to pH 7.6 if necessary.  
 
5x Lysis buffer 
0.5 mM Tris- HCl pH 7.5  6 ml 
150 nM NaCl    1.32 g 
0.5 mM EDTA   300 µl 
1 mM EGTA    57 mg 
2.4 mM natrium pyrophosphate 167 mg 
1 mM natrium orthovandat  27.6 mg 
Triton X-100    1500 µl 
Distilled water    30 ml 
 
1x Lysis buffer 
5x Lysis buffer  0.5ml 
10 mg/ml leupeptin   2.5 µl 
0.1M PMFS   25 µl 
10 mg/ml Pepstatin A  25 µl 
10 mg/ml Aprotenin  2.5 µl 
Distillated water  1968 µl 
 
Leupeptin 10 mg/ml 
Leupeptin (L-2884)   5 mg 





Aprotenin (A-1153)  10 mg 
Distillated water   1 ml 
 
Pepstatin A 10 mg/ml 
Pepstatin A (P-5318)  5 mg 
DMSO    500 µl 
 
5x SDS/ running buffer for Western 
0.5M Tris-HCl, pH 6.8 12,48 ml 
SDS    2 g 
Β- mercaptoetanol  5 ml 
1% Bromphenol blue (??) 1 ml   
Add distillated water up to  20 ml 
 
0.5M Tris-HCl, pH 6.8 
Tris HCl   17.8 g 
Tris- Base   1.7g 
Add distillated water up to  250 ml, adjust pH to 6.8 is necessary.  
 
10x Transfer buffer 
Tris-Base   30.3 g 
Glycine   144g 
Add distillated water up to  1000 ml 
 
10x Electhrophoresis buffer 
Tris-Base   30g 
Glycine   144g 
SDS    10 g 
Add distillated water up to  1000 ml 
 
1x Electhrophoresis buffer 
10x Electrophoresisbuffer   100 ml 




1x Transfer buffer 
10x Transferbuffer  100 ml 
Methanol    200 ml 
Distillated water  700 ml 
 
1% dry milk 
Skim milk powder  5g 
Add washing buffer to  500 ml 
 
3% dry milk 
Skim milk powder   15g 
Add washing buffer to  500 ml 
 





  500ml 
10mM Na2EDTA   1.86g 
Adjust to pH to 7.4 is necessary.  
 
Lysis stock 
Distilled water    3L 
2.5M NaCl     730.5g 
100mM Na2EDTA     186.0g 
10mM Trizma base    6.0g 
34mM NaOH     37.5g 
34mM N-Lauroylsarcosine sodium salt 50g 




Distilled water  4L 
3M NaOH   600g 
0.01M Na2EDTA  18.6g 




Stock   300 ml 
DMSO  33, 3 ml 
Triton X-100 3, 33 ml 
 
Electrophoresis solution (10x) 
Stock    200 ml 
HCl (37%)  12 ml 
Distilled water 1.8L  
 
Collins buffer 
Distilled water   4L 
40mM Hepes    47.65g 
0.1M KCl    37.25g 
0.5mM Na2EDTA   0.93g 
Add distillated water up to 5L, and adjust the pH to 7.6,  with 7M KOH 
 
Collins buffer with BSA (0.2 mg/ml) 
Collins buffer  200ml 
40 mg/ml BSA  1 ml 
 
Neutralization buffer (0.4M) 
Distilled water     4L 
0.32M Tris-HCl     254g 
0.08M Tris-base     47.2g 
Add distilled water to 5L, and adjust the pH to 7.5, with either HCl or NaOH. 
 
Na2EDTA stock 
0.2M Na2EDTA  7.5g 
Distilled water   100ml 
 
Tris-HCl stock 
0.5M Tris-HCL  39.4g 





Distilled water   0.8L 
0.2M  Na2EDTA (stock)  5ml  
0.5M Tris-HCl (stock)  20ml 
Adjust the pH to 8.0 
Add distilled water to 1L, adjust to pH 5.8 is necessary.  
 
Dulbecco’s PBS 
KCl  0.2 g 
KH2PO4 0.2 g 
NaCl  8 g 
Na2HPO4 1.15 g 




























Apoptosis: 3.45 % ±1.35 Living cells: 96 %  ± 1.76 
G1:  
61.85 % ± 2.66 
S: 
24.1 % ± 0.84 
G2:  





Apoptosis: 2.45 % ± 0.84 Living cells: 97.35 % ± 0.79 
G1:  
63.25 % ± 7.36 
S: 
24.75 % ± 4.69 
G2:  









Treatment with Camp. (10 
µM) and MMS (600µM)  





Apoptosis: 2.75 % ± 0.85 Living cells: 96.85 % ± 1.03 
G1:  
60.18 % ± 6.80 
S: 
28.13 % ± 4.61 
G2:  





Apoptosis: 2.28 % ± 0.92 Living cells: 97.4 % ± 0.89 
G1:  
56.08% ± 1.14 
S: 
29.7 % ± 4.62 
G2:  





Treatment with Camp. (10 
µM) 1h  
 
HEK-293 N750. 
Treatment with MMS (600µM)  





Apoptosis: 2.8 % ±1.08 Living cells: 96.6 % ± 1.24 
G1:  
64.58 % ± 4 
S: 
26.03 % ± 2.42 
G2:  








Apoptosis: 3.2 % ± 1.86 Living cells: 96.34 % ± 2.22 
G1:  
62.8 % ± 3.34 
S: 
26.85 % ± 1.38 
G2:  






Treatment with Camp. (10 µM) 











Apoptosis: 3.08 % ±2.07 Living cells: 96.45 % ± 2.16 
G1:  
58.48 % ± 8.45 
S: 
28.65 % ± 6.21 
G2:  





Apoptosis: 1.67  % ±0.66 Living cells: 98 %  ± 0.74 
G1:  
62.5 % ± 1.2 
S: 
22.3 % ± 0.76 
G2:  





Treatment with MMS (600µM)   






Treatment with Camp. (10 µM) 






Apoptosis: 1.67  % ±0.66 Living cells: 98 %  ± 0.74 
G1:  
62.5 % ± 1.2 
S: 
22.3 % ± 0.76 
G2:  





Apoptosis: 2.13 % ± 0.91 Living cells: 97.88 % ± 0.36 
G1:  
65.35 % ± 4.43 
S: 
21.2 % ± 2.02 
G2:  











Apoptosis: 2.13 % ± 0.91 Living cells: 97.88 % ± 0.36 
G1:  
65.35 % ± 4.43 
S: 
21.2 % ± 2.02 
G2:  







Apoptosis:  2.58 % ±1.80 Living cells: 97.85 % ± 0.41 
G1:  
67.68 % ± 1.90 
S: 
21.65 % ± 2.40 
G2:  







Treatment with MMS (600µM)  
1h and 15 min  
 
HEK-293K. 
Treatment with Camp. (10 µM) 







Apoptosis: 2.8 % ± 2.30 Living cells: 97.65 % ± 0.66 
G1:  
66.03 % ± 1.07 
S: 
23.98 % ± 0.57 
G2:  




Apoptosis: 2.8 % ± 2.30 Living cells: 97.65 % ± 0.66 
G1:  
66.03 % ± 1.07 
S: 
23.98 % ± 0.57 
G2:  














Treatment with MMS (600µM)   
5h and 15 min 
 
